Study Designed to Clinically Evaluate Sinus Wash Device Prototypes
Primary Purpose
Sinusitis, Maxillary Sinusitis
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
SinuSafe Medical Device for Maxillary Sinus
Sponsored by
About this trial
This is an interventional treatment trial for Sinusitis focused on measuring sinus wash, sinus lavage, Sinusitis
Eligibility Criteria
Inclusion Criteria:
- Male or female, 18-65 years of age.
- Signs and symptoms of acute exacerbation during chronic maxillary sinusitis.
- Pain higher than 5 in VAS of 0-10.
- Able to understand and provide written informed consent.
Exclusion Criteria:
- Patients who have a clinically significant or unstable medical or surgical condition that may preclude safe and complete study participation as determined by medical history based on the opinion of the investigator.
- Extensive sinonasal polyps that may interfere with the treatment procedure.
- Previous sinonasal surgery.
- Acute exacerbation of sinusitis in the frontal or sphenoid sinuses.
- Sinonasal osteoneogenesis.
- Cystic fibrosis.
- Sinonasal tumors or obstructive lesions.
- Presence of features consistent with sinus fungal disease on CT or physical examination.
- History of facial trauma that distorted the sinus anatomy.
- Ciliary dysfunction.
- History of insulin dependent diabetes.
- Not able to stop anti-coagulant (e.g., warfarin) until the International Normalized Ratio (INR) is below 1.5.
- Not able to stop anti-platelet (e.g., clopidogrel, aspirin, etc.) for at least 14 days prior to study procedure.
- Not able to stop any non-steroidal anti-inflammatory medications and homeopathic medications for at least 14 days prior to the study procedure.
- Pregnancy.
- Psychiatric disease.
- Currently participating in other drug or device studies.
- Investigator's opinion that the subject should not be in the study such as any conditions that could compromise the wellbeing of the patient or integrity of the study or prevent the patient from meeting or performing study requirements.
- Patient is not capable of following the study schedule for any reason.
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Sinus irrigation
Arm Description
Sinus irrigation intervention
Outcomes
Primary Outcome Measures
Adverse events
Presence of adverse events
Secondary Outcome Measures
Mucosal damage visual inspection
Visual inspection of sinus mucosa with the endoscope looking for mucosal damage.
Syringe visual inspection
Visual inspection of the aspirated liquids looking for bleeding. Excess nasal bleeding shall be defined as a doctor decision to use sinus or nasal packing.
Pain during procedure
Pain during procedure with the VAS pain scale
Usability & Tolerability Questionnaire
Usability & Tolerability Questionnaire
Mucus leftovers visual inspection
Visual inspection of sinus mucosa with the endoscope looking for mucus leftovers
Mucus aspiration into the syringe
Mucus aspiration into the syringe (yes/ no and time)
Pain relief
Pain relief in the post-treatment VAS pain scale
Time measurements of cannula insertion.
Time measurements of cannula insertion
Time measurements of irrigation and aspiration
Time measurements of irrigation and aspiration
SNOT 20 questionnaire
SNOT 20 questionnaire (Hebrew version) to evaluate the patient's severity level before the treatment
Full Information
NCT ID
NCT02931604
First Posted
September 13, 2016
Last Updated
October 10, 2016
Sponsor
SinuSafe Medical LTD
1. Study Identification
Unique Protocol Identification Number
NCT02931604
Brief Title
Study Designed to Clinically Evaluate Sinus Wash Device Prototypes
Official Title
Pilot Study Designed to Clinically Evaluate Sinus Wash Device Prototypes in Patients With Sinusitis During Endoscopic Sinus Surgery (ESS) and in the Hospital Outpatient
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Unknown status
Study Start Date
January 2017 (undefined)
Primary Completion Date
November 2019 (Anticipated)
Study Completion Date
January 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
SinuSafe Medical LTD
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to clinically evaluate sinus wash device prototypes in patients with sinusitis during Endoscopic Sinus Surgery (ESS) and in the hospital outpatient
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sinusitis, Maxillary Sinusitis
Keywords
sinus wash, sinus lavage, Sinusitis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Sinus irrigation
Arm Type
Experimental
Arm Description
Sinus irrigation intervention
Intervention Type
Device
Intervention Name(s)
SinuSafe Medical Device for Maxillary Sinus
Intervention Description
Sinus lavage via the natural sinus ostium, without ostial dilation.
Primary Outcome Measure Information:
Title
Adverse events
Description
Presence of adverse events
Time Frame
Within day 1
Secondary Outcome Measure Information:
Title
Mucosal damage visual inspection
Description
Visual inspection of sinus mucosa with the endoscope looking for mucosal damage.
Time Frame
Within 1 hour
Title
Syringe visual inspection
Description
Visual inspection of the aspirated liquids looking for bleeding. Excess nasal bleeding shall be defined as a doctor decision to use sinus or nasal packing.
Time Frame
Within 1 hour
Title
Pain during procedure
Description
Pain during procedure with the VAS pain scale
Time Frame
Within 1 hour
Title
Usability & Tolerability Questionnaire
Description
Usability & Tolerability Questionnaire
Time Frame
Within 1 hour
Title
Mucus leftovers visual inspection
Description
Visual inspection of sinus mucosa with the endoscope looking for mucus leftovers
Time Frame
Within 1 hour
Title
Mucus aspiration into the syringe
Description
Mucus aspiration into the syringe (yes/ no and time)
Time Frame
Within 1 hour
Title
Pain relief
Description
Pain relief in the post-treatment VAS pain scale
Time Frame
Within 1 hour
Title
Time measurements of cannula insertion.
Description
Time measurements of cannula insertion
Time Frame
Within 1 hour
Title
Time measurements of irrigation and aspiration
Description
Time measurements of irrigation and aspiration
Time Frame
Within 1 hour
Title
SNOT 20 questionnaire
Description
SNOT 20 questionnaire (Hebrew version) to evaluate the patient's severity level before the treatment
Time Frame
Within 1 hour
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or female, 18-65 years of age.
Signs and symptoms of acute exacerbation during chronic maxillary sinusitis.
Pain higher than 5 in VAS of 0-10.
Able to understand and provide written informed consent.
Exclusion Criteria:
Patients who have a clinically significant or unstable medical or surgical condition that may preclude safe and complete study participation as determined by medical history based on the opinion of the investigator.
Extensive sinonasal polyps that may interfere with the treatment procedure.
Previous sinonasal surgery.
Acute exacerbation of sinusitis in the frontal or sphenoid sinuses.
Sinonasal osteoneogenesis.
Cystic fibrosis.
Sinonasal tumors or obstructive lesions.
Presence of features consistent with sinus fungal disease on CT or physical examination.
History of facial trauma that distorted the sinus anatomy.
Ciliary dysfunction.
History of insulin dependent diabetes.
Not able to stop anti-coagulant (e.g., warfarin) until the International Normalized Ratio (INR) is below 1.5.
Not able to stop anti-platelet (e.g., clopidogrel, aspirin, etc.) for at least 14 days prior to study procedure.
Not able to stop any non-steroidal anti-inflammatory medications and homeopathic medications for at least 14 days prior to the study procedure.
Pregnancy.
Psychiatric disease.
Currently participating in other drug or device studies.
Investigator's opinion that the subject should not be in the study such as any conditions that could compromise the wellbeing of the patient or integrity of the study or prevent the patient from meeting or performing study requirements.
Patient is not capable of following the study schedule for any reason.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Avinoam Gemer
Phone
972-544-858822
Email
avinoamgemer@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Itzhak Braverman, Professor
Organizational Affiliation
Hillel Yaffe Medical Center
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Study Designed to Clinically Evaluate Sinus Wash Device Prototypes
We'll reach out to this number within 24 hrs